Open access · CC-BY
via OpenAlex
MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism
Yen My Vuu, Chris-Tiann Roberts, Mojgan Rastegar
International Journal of Molecular Sciences · 2023 · ▲ 51 citations
Abstract
DNA methylation, one of the most well-studied epigenetic modifications, is involved in a wide spectrum of biological processes. Epigenetic mechanisms control cellular morphology and function. Such regulatory mechanisms involve histone modifications, chromatin remodeling, DNA methylation, non-coding regulatory RNA molecules, and RNA modifications. One of the most well-studied epigenetic modifications is DNA methylation that plays key roles in development, health, and disease. Our brain is probably the most complex part of our body, with a high level of DNA methylation. A key protein that binds to different types of methylated DNA in the brain is the methyl-CpG binding protein 2 (MeCP2). MeCP2 acts in a dose-dependent manner and its abnormally high or low expression level, deregulation, and/or genetic mutations lead to neurodevelopmental disorders and aberrant brain function. Recently, some of MeCP2-associated neurodevelopmental disorders have emerged as neurometabolic disorders, suggesting a role for MeCP2 in brain metabolism. Of note, MECP2 loss-of-function mutation in Rett Syndrome is reported to cause impairment of glucose and cholesterol metabolism in human patients and/or mouse models of disease. The purpose of this review is to outline the metabolic abnormalities in MeCP2-associated neurodevelopmental disorders that currently have no available cure. We aim to provide an updated overview into the role of metabolic defects associated with MeCP2-mediated cellular function for consideration of future therapeutic strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms24044218
- Canonical
- link ↗
- Fetched
- 2026-10-04 MST
Cite this
APA
Vuu, Y.M., Roberts, C., & Rastegar, M. (2023). MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms24044218
Vancouver
Vuu YM, Roberts C, Rastegar M. MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044218.
BibTeX
@article{yen2023MeCPIs,
title = {MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism},
author = {Yen My Vuu and Chris-Tiann Roberts and Mojgan Rastegar},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044218},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2021
Open access · CC-BY
The Role of Gut Microbiota in an Ischemic Stroke
Osteoarthritis and Cartilage 2012
Open access · OA
Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs
Nature Reviews Neurology 2025
Preprint · CC-BY
Epigenetic clocks and DNA methylation biomarkers of brain health and disease
International Journal of Molecular Sciences 2024
Open access · CC-BY
An Overview of the Epigenetic Modifications in the Brain under Normal and Pathological Conditions
Journal of Neurochemistry 2016
Open access · OA
DNA methylation in Parkinson's disease
Frontiers in Genetics 2019
Open access · CC-BY